Insider · CIK 0001270354
Marla Persky
Files at XERS (Xeris Biopharma Holdings, Inc.). First filing Nov 15, 2023, latest Jun 5, 2026.
In brief
Marla Persky files SEC Form 4 as director at XERS (Xeris Biopharma Holdings, Inc.). Since Nov 15, 2023, Marla Persky has reported 1 open-market buy worth $10k and 2 open-market sells worth $211k, the latest filed on Jun 5, 2026.
A track record needs three past buys with six months of prices behind them; Marla Persky has 0, so none is measured yet.
The newest scored trade: sold $91k of XERS on Jun 3, 2026, filed Jun 5, 2026, scored 24 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 1 sell worth $91k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
XERS: Xeris Biopharma Holdings, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 24Weak | Xeris Biopharma Holdings, Inc. | $91k 15,500 shares | -11% | +35% from low-41% from high | |
| 13Weak | Xeris Biopharma Holdings, Inc. | $120k 15,500 shares | -10% | +178% from low-4% from high | |
| 46Moderate | Xeris Biopharma Holdings, Inc. | $10k 6,370 shares | - | +51% from low-48% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jun 3, 2026 | XERS XERIS BIOPHARMA HOLDINGS, INC. | 15,500 0.01% of outstanding | $93k | Jun 3, 2026 | none |
| Sep 11, 2025 | XERS XERIS BIOPHARMA HOLDINGS, INC. | 15,500 0.01% of outstanding | $121k | Sep 11, 2025 | none |
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 3, 2026 | XERS Xeris Biopharma Holdings, Inc. | SOpen-market sale Common Stock10b5-1 | -15,500 | $5.90 | $91k | 126,500 | Jun 5, 2026 |
| Jun 4, 2026 | XERS Xeris Biopharma Holdings, Inc. | AGrant or award Common Stock10b5-1 | +24,193 | $0.00 | $0 | 150,693 | Jun 5, 2026 |
| Jun 4, 2026 | XERS Xeris Biopharma Holdings, Inc. | AGrant or award Stock Option (Right to Buy)derivative10b5-1 | +32,996 | $6.15 | $203k | 32,996 | Jun 5, 2026 |
| Sep 11, 2025 | XERS Xeris Biopharma Holdings, Inc. | SOpen-market sale Common Stock10b5-1 | -15,500 | $7.72 | $120k | 142,000 | Sep 12, 2025 |
| Jun 4, 2025 | XERS Xeris Biopharma Holdings, Inc. | AGrant or award Common Stock | +50,000 | $0.00 | $0 | 157,500 | Jun 4, 2025 |
| Nov 14, 2023 | XERS Xeris Biopharma Holdings, Inc. | POpen-market purchase Common Stockindirect: By: Marla Susan Persky Revocable Trust u/a dated 9/23/2000 | +6,370 | $1.58 | $10k | 6,370 | Nov 15, 2023 |
Questions about Marla Persky
Answered from the filings on this page, as of the latest one.
Is Marla Persky buying or selling?
In the last 12 months Marla Persky reported 0 open-market buys worth $0 and 1 open-market sell worth $91k on SEC Form 4; the latest was sold $91k of XERS on Jun 3, 2026. Grants, option exercises and tax withholding are not counted.
How did Marla Persky's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Marla Persky has 0.
Where does Marla Persky file Form 4?
Marla Persky has filed Form 4 at XERS (Xeris Biopharma Holdings, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.